On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended ...
The practice patterns and outlook of gynecology oncologists in the treatment of pediatric, adolescent and young adults with gynecologic malignancies: A survey study. This is an ASCO Meeting Abstract ...
Newborn screening for an inherited genetic condition that affects people of several ethnicities could reduce the risk of long-term disability for many on Long Island, doctors and advocates say.
In an April 8 MedPage Today article, Mark Zucker, MD, asked the question as to why there is differential susceptibility to COVID-19 infection. In other words, why do some people become severely ill ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A woman eagerly awaiting the sound of her baby’s heartbeat was met with ...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked enzymopathy that reduces cellular capacity to produce NADPH, compromising redox balance in erythrocytes. In malaria-endemic ...
HbA1c is the world’s most widely used test for diagnosing type 2 diabetes. New evidence shows that G6PD deficiency and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results